Please provide your email address to receive an email when new articles are posted on . A workshop of health professionals, patients and caregivers recommended that a core outcome measure for ...

DUBAI, United Arab Emirates--(BUSINESS WIRE)--Banuba, a leading provider of augmented reality (AR) solutions, is excited to announce the addition of a cutting-edge pupillary distance (PD) measurement ...

Prevalence of autoimmune conditions among patients with lung cancer: Implications for immunotherapy treatment options. This is an ASCO Meeting Abstract from the 2016 ASCO Annual Meeting I. This ...

Effect of adenoviral p53 (Ad-p53) tumor suppressor immune gene therapy on checkpoint inhibitor resistance and abscopal therapeutic efficacy. This is an ASCO Meeting Abstract from the 2017 ASCO Annual ...

Extracellular interaction between programmed death ligand-1 (PD-L1) and programmed cell death protein-1 (PD-1) leads to tumour-associated immune escape. Here we show that the immunosuppression ...

A first-in-class peptide-based PET tracer, 18 F-AlF-NOTA-PCP2, can effectively measure PD-L1 expression in patients with head and neck cancers, outperforming the conventional tracer 18 F-FDG. 18 F-AlF ...